Blood Irradiator Market -Regional Insights
On the basis of region, theglobal BloodIrradiator Market is segmented into North America, Latin America, Europe,Asia Pacific, Middle East, and Africa. North America holds dominant position inthe global blood irradiators market, owing to the launch and adoption of noveltechnologies. For instance, in September 2017, Typenex Medical, launchedRad-Control, a new irradiation indicator tag technology in the blood banks andblood centers in the U.S. and Canada. Rad-control ensures that blood componenthas received irradiation, thereby preventing life threateningtransfusion-associated Graft-vs.-Host Disease (TA-GvHD).
Furthermore, increasing adoptionof X-ray irradiators is expected to fuel the blood irradiator market growth. In2017, the U.S. Department of Energy’s National Nuclear Security Administration(DOE/NNSA) partnered with the New York City Department of Health and MentalHygiene (DOHMH) and the Nuclear Threat Initiative (NTI) to replace theradioactive irradiators with the safer X-ray alternatives.
Blood irradiators are used toirradiate blood and blood components to prevent the proliferation of Tlymphocytes that can inhibit the immune response leading to graft-versus-hostdisease (GVHD). The blood irradiators are widely used in various medical andresearch applications such as preparing blood for transfusion and cancerresearch. Irradiation procedure is necessary for transfusion recipients at riskfor GVHD, including fetuses receiving intrauterine transfusions, patientsundergoing hematopoietic transplantation, and individuals receiving platelets.Blood irradiators has applications in irradiation of blood, which is essentialfor surgeries, cancer treatment, chronic illnesses, and traumatic injuries.
* The sample copy includes:Report Summary, Table of Contents, Segmentation, Competitive Landscape, ReportStructure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/1972
Blood Irradiator Market Drivers
Irradiated blood is provided toprevent rare complications of transfusion called transfusion- associatedgraft-versus-host disease, a rare but serious complication of blood transfusioncaused by white blood cells in the blood transfused. According to the RoyalChildren’s Hospital Melbourne, transfusion- associated graft-versus-hostdisease (TA-GVHD) occurs when donor lymphocytes from transfused blood engraftin the recipient, causing diseases such as hepatitis, diarrhea and pancytopeniawith clinical features of fever and skin rash and is fatal in more than 90% ofcases.
Moreover, support from governmentorganizations for development of novel irradiators to ensure safe bloodtransfusions is driving market growth. For instance, in 2014, Stellarray, Inc.,developer of novel x-ray sources, was awarded the US$ 1.1 Mn grant by theDepartment of Energy to develop and commercialize new generation irradiatorsfor ensuring the safety of blood transfusions by replacing cesium, 137 which isidentified as a national security hazard.
Moreover, the AdvancingTransfusion Cellular Therapies Worldwide (AABB) works in collaboration with theFood and Drug Administration (FDA) to ensure appropriate irradiation guidanceand regulations for blood products, thereby favoring the blood irradiatorsmarket by maintaining security and compliance to limit the use of radioactiveirradiators.
However, the lack of awarenessamong population regarding uses and benefits of irradiators in the healthcarefacilities and high cost of the irradiators are the factors hindering themarket growth. For instance, according to the survey by College of AmericanPathologists, 2017, the cost of X-ray irradiators is around US$ 250,000 to US$300,000, with annual service contract accounting for US$ 15,000 to US$ 20,000.
Browse ResearchReport: https://www.coherentmarketinsights.com/ongoing-insight/blood-irradiator-market-1972
Moreover, increasing number ofcases requiring blood transfusions related to various diseases in the region isa major factor favoring the market growth. According to the American NationalRed Cross, sickle cell disease affects 90,000 to 100,000 people in the U.S.,and about 1,000 babies are born with the disease annually. The sickle cellpatients mostly require blood transfusions throughout their lives. Also,according to the American Cancer Society, about 1.7 million people are expectedto be diagnosed with cancer in 2017, where the patients require blood duringthe chemotherapy treatment.
Moreover, high adoption of bloodirradiators in the medical settings to prevent and control the transmission oftransfusion associated graft-versus-host disease (TA-GVHD) is expected topropel market growth in the North America. According to the Department ofHealth and Human Services, 2013, around 500 blood irradiators irradiated around2 million blood units in 2013.
Blood Irradiator Market -Competitive Landscape
Key players in the global bloodirradiator market are focused on strategic mergers and acquisitions to promotethe blood irradiators in the global market. For instance, Charter Medicalcollaborated with RadTag Technologies to distribute the RadTag blood irradiatorindicators in the U.S.
Some of the key players operatingin the global blood irradiator market include Rad Source Technologies, SukosolGroup, Typenex Medical, Gamma-Service Medical GmbH, Cegelec NDT-PES, and BestTheratronics, Ltd.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/1972
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollar opportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
